The Health Resources and Services Administration proposed another delay, this time until July 2018, of a rule on the 340B drug discount program that sets ceiling prices and civil monetary penalties as the agency considers changing the regulation. Some drug makers want the agency to revamp the rule but 340B hospitals want HRSA to implement it. HRSA finished the rule shortly before President Obama left office, and this proposal marks the fourth time the Trump administration has tried to delayed...